This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, T. T.
Right arrow Articles by Miyamoto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, T. T.
Right arrow Articles by Miyamoto, S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2001, p. 4737-4747, Vol. 21, No. 14
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.14.4737-4747.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Postrepression Activation of NF-kappa B Requires the Amino-Terminal Nuclear Export Signal Specific to Ikappa Balpha

Tony T. Huang and Shigeki Miyamoto*

Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin---Madison, Madison, Wisconsin 53706-1532

Received 31 January 2001/Accepted 24 April 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

One of the most prominent NF-kappa B target genes in mammalian cells is the gene encoding one of its inhibitor proteins, Ikappa Balpha . The increased synthesis of Ikappa Balpha leads to postinduction repression of nuclear NF-kappa B activity. However, it is unknown why Ikappa Balpha , among multiple Ikappa B family members, is involved in this process and what significance this feedback regulation has beyond terminating NF-kappa B activity. Herein, we report an important Ikappa Balpha -specific function dictated by its amino-terminal nuclear export sequence (N-NES). The Ikappa Balpha N-NES is necessary for the postinduction export of nuclear NF-kappa B, which is a critical event in reestablishing a permissive condition for NF-kappa B to be rapidly reactivated. We show that although Ikappa Balpha and another Ikappa B member, Ikappa Bbeta , can enter the nucleus and repress NF-kappa B DNA-binding activity during the postinduction phase, only Ikappa Balpha allows the efficient export of nuclear NF-kappa B. Moreover, swapping the N-terminal region of Ikappa Bbeta for the corresponding Ikappa Balpha sequence is sufficient for the Ikappa B chimera protein to export NF-kappa B similarly to Ikappa Balpha during the postinduction state. Our findings provide a mechanistic explanation of why Ikappa Balpha but not other Ikappa B members is crucial for postrepression activation of NF-kappa B. We propose that this Ikappa Balpha -specific function is important for certain physiological and pathological conditions where NF-kappa B needs to be rapidly reactivated.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The NF-kappa B/Rel family of inducible transcription factors is involved in the expression of numerous genes involved in important cellular and physiological processes such as growth, development, apoptosis, and inflammatory and immune responses (15, 45). Members of the Rel family include p65 (RelA), p105/p50, p100/p52, RelB, and c-Rel. These transcription factors can form homo- or heterodimers with each other to make transcriptionally competent or repressive complexes, loosely referred to as the nuclear factor kappa B (NF-kappa B). The biological activity of NF-kappa B is tightly regulated by its inhibitor protein, Ikappa B. Members of the Ikappa B family include Ikappa Bbeta , Ikappa Bgamma , Ikappa Bvarepsilon , Bcl-3, and the best-characterized member, Ikappa Balpha (15). In most cells, Ikappa Balpha and Ikappa Bbeta are found associated with the p50-p65 heterodimer, the most ubiquitous NF-kappa B, to form a stable trimeric complex inside the cell.

The subcellular localization of NF-kappa B-Ikappa B complexes dictates the ability of NF-kappa B to be activated by extracellular stimuli such as tumor necrosis factor alpha (TNF-alpha ). We and others have previously shown that cytoplasmic localization of preinduced NF-kappa B-Ikappa B complexes is important for efficient cytokine-dependent phosphorylation-ubiquitination and subsequent degradation of Ikappa B proteins, which cause the release of NF-kappa B to the nucleus to alter gene expression (17, 38). Nuclear NF-kappa B-Ikappa B complexes, however, are generally refractory to cytokine-induced Ikappa B degradation. These observations suggest that cytoplasmic localization of NF-kappa B-Ikappa B complexes plays an important role during the pre- and postinduced stages of NF-kappa B activation.

Localization of preinduced NF-kappa B population is partly controlled by an N-terminal nuclear export signal (N-NES) on Ikappa Balpha (17, 23, 38, 43). NF-kappa B complexes formed with Ikappa Balpha have a tendency to shuttle rapidly between the cytoplasm and nucleus, likely due to leaky exposure of p50 nuclear localization signal (NLS) coupled to a more dominant nuclear export by Ikappa Balpha (17, 22). However, it is unknown whether Ikappa Bbeta or other Ikappa B members bound to NF-kappa B can also shuttle nucleocytoplasmically in the absence of stimuli.

The localization of postinduced nuclear NF-kappa B population is also carefully controlled, presumably by Ikappa Balpha (1, 47). Postinduction repression refers to the condition in which activated nuclear NF-kappa B upregulates the expression of Ikappa Balpha due to NF-kappa B consensus binding sites within the Ikappa Balpha promoter (7, 8, 21, 27, 42), followed by nuclear accumulation of free Ikappa Balpha , which dissociates NF-kappa B from NF-kappa B-bound DNA complexes to repress NF-kappa B function (2). These newly formed nuclear NF-kappa B-Ikappa Balpha complexes are then exported out to the cytoplasm, thereby reestablishing the cytoplasmic pool of inactive NF-kappa B complexes that are primed for another round of activation to take place (2). Recent reports have shown intrinsic nuclear export functions in both Ikappa Balpha (2, 17, 23, 38, 39, 43) and the p65 subunit of NF-kappa B complexes (16). However, it remains to be determined which of these newly characterized NESs can facilitate postinduction export of nuclear NF-kappa B complexes.

The leucine-rich NES motif is an evolutionarily conserved sequence used by a variety of proteins to facilitate their delivery from the nucleus to the cytoplasm and is also used as an important point of control by the cell to regulate protein function through subcellular localization (24, 28). Leptomycin B (LMB) is an extremely useful tool used to selectively inhibit Crm1 (exportin-1)-dependent nuclear export of NES-containing proteins (10, 11, 26, 35, 41). LMB appears to covalently modify Crm1 export receptor at a conserved cysteine residue that renders the receptor incapable of forming the exporting trimeric complex between cargo protein and RanGTP (25).

In the present study, we provide evidence that Ikappa Balpha may be the only NF-kappa B inhibitor protein to possess an intrinsic nuclear export function. We employed LMB, knockout cells, chimeric constructs, and transient and stable transfection studies to monitor subcellular localization of NF-kappa B-Ikappa B complexes, degradation of Ikappa B proteins, and NF-kappa B DNA-binding activities during pre-and postinduction states. We found that N-NES of Ikappa Balpha is primarily responsible for export of NF-kappa B during pre- and postinduction states. However, NF-kappa B-Ikappa Bbeta complexes are incapable of shuttling during both of these states, suggesting that, unlike Ikappa Balpha , Ikappa Bbeta is capable of completely masking nuclear localization sequences of the NF-kappa B dimer and incapable of exporting the complex out of the nucleus. Swapping the N-terminal region of Ikappa Bbeta for Ikappa Balpha sequence allows NF-kappa B bound to the chimeric protein to be exported out of the nucleus in a manner identical to Ikappa Balpha . These results provide deeper insights into the fundamental differences between regulatory mechanisms governing function of Ikappa Balpha and Ikappa Bbeta and possibly other Ikappa B members and implicate biological relevance of Ikappa Balpha -specific nuclear export function in regulation of such processes as apoptosis and inflammatory responses.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell culture. Mouse embryo fibroblasts (MEFs), 293 human embryonic kidney cells (HEK), and Cos-7 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Cellgro) supplemented with 10% fetal bovine serum (HyClone Laboratory, Inc.), 1,000 U of penicillin G (Sigma Chem. Co., St. Louis, Mo.), and 0.5 mg of streptomycin sulfate (Sigma) per ml in a humidified 10% CO2 incubator (Forma Scientific). The p65-/- 3T3 cells were maintained in DMEM with 10% bovine calf serum and supplemented with antibiotics as above. Cells (embryonic fibroblasts and Cos-7) were transiently transfected using the Effectene transfection reagent (Qiagen) and the standard calcium phosphate precipitation method (5).

Reagents. Dimethyl sulfoxide (DMSO) and cycloheximide were purchased from Sigma. MG132 was purchased from Peptides International. Human recombinant TNF-alpha was from CalBiochem and resuspended in phosphate-buffered saline (PBS) containing 0.1% bovine serum albumin (fraction V; Sigma). In each experiment, all samples received the same amounts of DMSO to control for potential DMSO effects. Immunoglobulin G (IgG) antibodies against Ikappa Balpha (C21), Ikappa Bbeta (C20), and p65 (C20) were purchased from Santa Cruz Biotechnology. The 5432 rabbit polyclonal antibody was raised against the N-terminal 56 amino acids of murine Ikappa Balpha conjugated to glutathione S-transferase as described previously (30). A monoclonal anti-HA.11 (influenza virus hemagglutinin epitope) antibody was purchased from BabCO, and horseradish peroxidase-conjugated anti-rabbit and anti-mouse Ig antibodies were obtained from Amersham. Fluorescein isothiocyanate (FITC)- and tetramethyl rhodamine isocyanate (TRITC)-conjugated anti-rabbit and anti-mouse Ig antibodies were purchased from Sigma. Hoechst dye 33342 and rhodamine phalloidin (R-415) were purchased from Molecular Probes.

Western blot and EMSA procedures. Cell preparation and Western immunoblots were performed as described (31) and developed using the enhanced chemiluminescent (ECL) procedure according to the manufacturer (Amersham). Blots were then exposed to X-ray film (Kodak). The Igkappa -kappa B oligonucleotide probe and conditions for electrophoretic mobility shift assay (EMSA) were previously described (31). The total cell extract buffer (20 mM HEPES [pH 7.9], 350 mM NaCl, 20% glycerol, 1% NP-40, 1 mM MgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 0.5 mM dithiothreitol, phenylmethylsulfonyl fluoride, and aprotinin) was used for both Western blot analysis and EMSA. Nuclear and cytoplasmic biochemical fractionations were accomplished using buffer C and buffer A, respectively, as described (31).

Construction of Ikappa Balpha , Ikappa Bbeta and p65 chimeras and fusion proteins. N-terminally fused green fluorescent protein (GFP)-Ikappa Balpha was generated by subcloning PCR-amplified human wild-type Ikappa Balpha (MAD3) into the HindIII and BamHI sites of the pEGFP vector (Clontech). The human p65 cDNA was kindly provided by D. Ballard (Vanderbilt, Tenn.). To make the GFP N-terminally tagged p65 fusion protein, the p65 cDNA with HindIII and BamHI flanking sites was created by PCR and ligated in-frame into the pEGFP vector (Clontech). Truncated p65s (amino acids [aa] 1 to 420 and 1 to 450) were made with 3' primers specific to the C-terminal truncated portion of p65 and subcloned into the pEGFP vector as above. The murine p65 cDNA was blunt-end ligated into BamHI-NheI Klenow blunt-ended pCMX vector (provided by K. Umesono, Kyoto University). Similarly, CMX-p50 was generated by cleaving murine p105 cDNA at NcoI sites, Klenow filled, and blunt-ligated into BamHI-NheI Klenow blunt-ended pCMX vector. Ikappa Bbeta expression vector was constructed by inserting murine Ikappa Bbeta cDNA into pcDNA vector (Clontech). The amount of each plasmid vector was titrated to ensure the formation of Ikappa Balpha and NF-kappa B complexes in Cos-7 cells and MEFs. The Ikappa Balpha beta beta construct (pLHL-CA-Ikappa Balpha beta beta ) was made by using specific primer sets with either 3' Ikappa Balpha or 5' Ikappa Bbeta overhangs to PCR amplify pBS-Ikappa Balpha (1 to 66) and pBS-Ikappa Bbeta (45 to 359). The two PCR products were joined by PCR using 5' Ikappa Balpha and 3' Ikappa Bbeta -specific primers, subcloned into pBS at 5' BamHI and 3' XhoI, and subcloned into pLHL-CA vector at 5' BamHI-BglII and 3' XhoI sites. The N-NES mutant Ikappa Balpha beta beta construct was constructed similarly to the Ikappa Balpha beta beta construct except that the pBS-Ikappa Balpha N-NES mutant construct was used as a template. The pBS-Ikappa Balpha N-NES mutant template was generated using two-step PCR mutagenesis as described (17). The hemagglutinin (HA)-tagged murine Ikappa Balpha gene (pLHL-CAHA-mIkappa Balpha ) was constructed as described previously (31).

Visual analysis of NF-kappa B and Ikappa Balpha proteins. MEFs and Cos-7 cell lines were cultured in two-or four-welled chamber slides (Lab-Tek) and transiently transfected with various expression plasmid constructs. After drug treatment, cells were washed twice with ice-cold PBS and fixed with 3.7% formaldehyde in PBS for several hours at 4°C. Fixed cells were then rinsed with PBS and permeabilized with 0.2% Triton X-100 in PBS. Cells were blocked with 2% normal goat serum for 1 h and subsequently incubated with appropriate primary antibodies in PBS-0.2% Tween 20-2% goat serum at 37°C overnight. Staining was detected with either FITC- or TRITC-conjugated anti-mouse or -rabbit Ig secondary antibodies. Cells were mounted with Prolong Antifade (Molecular Probes) and visualized and photographed using a Zeiss Axioplan epifluorescence microscope with the aid of fluorescein- or rhodamine-specific filters. GFP fusion protein was visualized directly in living cells or under fixed conditions.

Generation of stable pools of MEFs. MEFs deficient for Ikappa Balpha were reconstituted with either HA-tagged murine Ikappa Balpha or the chimeric Ikappa Balpha beta beta gene via retroviral infection as described previously (31). Briefly, pLHL-CAHA-mIkappa Balpha or pLHL-CA-Ikappa Balpha beta beta and pLHL-CA-Ikappa Balpha beta beta N-NESmut constructs were contransfected with pCLeco (32) helper virus in HEK 293 cells. Viruses were then harvested and transferred onto MEFs for infection. Stably infected pools of MEFs were selected in the presence of hygromycin. The stable pools of MEFs were then grown in the absence of hygromycin for 2 days before experiments were initiated.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

LMB cannot inhibit activation of NF-kappa B associated with Ikappa Bbeta . It is known that nuclear export of NF-kappa B can be mediated by the Ikappa Balpha protein. It is yet unclear whether the capacity to export NF-kappa B out of the nucleus is a general function of all Ikappa B family members. Scanning the primary amino acid sequences of other Ikappa B members, such as Ikappa Bbeta (44), p105/Ikappa Bgamma (14, 20, 37), p100 (29, 33), Ikappa Bvarepsilon (46), and Bcl-3 (34), or cactus (13), the Drosophila homolog of Ikappa B, revealed no conserved NES motifs N-terminal of the first ankyrin repeat compared to Ikappa Balpha (Fig. 1A; others not shown). Since Ikappa Bbeta is widely expressed and responds to stimulus-dependent degradation in a manner similar to Ikappa Balpha , we chose to compare and contrast the mechanistic differences in the ability of Ikappa Balpha and Ikappa Bbeta to modulate NF-kappa B localization and activation. Consistent with earlier reports (17, 38), TNF-alpha -induced NF-kappa B DNA-binding activity was inhibited by LMB (Fig. 1B, lower panel, lanes 2 and 3). However, surprisingly, LMB had no observable effect against TNF-alpha -induced NF-kappa B activation in Ikappa Balpha knockout cells (Fig. 1B, lower panel, lanes 6 and 7). Although TNF-alpha induced the degradation of both Ikappa Balpha and Ikappa Bbeta in the wild-type cells, LMB selectively retarded the degradation of Ikappa Balpha , not Ikappa Bbeta (Fig. 1B, upper panel, lanes 2 and 3). Likewise, Ikappa Bbeta was degraded by TNF-alpha stimulation but was not inhibited upon pretreatment with LMB in the Ikappa Balpha -deficient cells (Fig. 1B, upper panel, lanes 6 and 7). These results show that LMB inhibits NF-kappa B activation only through the Ikappa Balpha protein. Together with a recent finding of the presence of a functional NES on p65 but not on the p50 or c-Rel subunit of NF-kappa B (16), our data suggest that the p65 NES does not dominantly affect Ikappa Bbeta subcellular localization in an LMB-sensitive fashion. Alternatively, unlike Ikappa Balpha , Ikappa Bbeta completely masks both nuclear localization sequences present on dimeric NF-kappa B complexes, thereby preventing import of NF-kappa B in the uninduced state. In the latter case, NF-kappa B-Ikappa Bbeta complexes do not shuttle in an NES-dependent manner, making their subcellular localization LMB insensitive.


View larger version (37K):
[in this window]
[in a new window]
 
FIG. 1.   Ikappa Bbeta is refractory to LMB inhibition of TNF-alpha -induced degradation. (A) N-terminal primary amino acid sequence alignment of Ikappa Balpha and Ikappa Bbeta . Boxed region signifies the highly conserved Ikappa B kinase phosphorylation sites on the dual serines on Ikappa Balpha and Ikappa Bbeta . Highlighted sequences (shaded box) are the recently identified "leucine-rich" N-terminal NES of Ikappa Balpha that is not conserved in other Ikappa B proteins such as Ikappa Bbeta , Ikappa Bvarepsilon , and cactus. (B) Wild-type and Ikappa Balpha -deficient MEFs were untreated or treated with TNF-alpha (10 ng/ml for 15 min; lanes 2 to 4 and 6 to 8) in the presence or absence of LMB (20 ng/ml; lanes 3 and 7) or MG132 (30 µM; lanes 4 and 8) pretreatment for 30 min. Total cell extracts were analyzed by EMSA by using an Igkappa -kappa B probe (lower panel) and by Western blotting with Ikappa Balpha (C-21) and Ikappa Bbeta (C-20) antibodies (upper panel). (C) p65-deficient 3T3 cells were treated with TNF-alpha (10 ng/ml for 15 min; lanes 2 to 5) and pretreated in the presence or absence of LMB (20 ng/ml) for 15, 30, or 60 min (lanes 3, 4, and 5, respectively). Total cell extracts were analyzed by EMSA as described above (lower panel) and by Western blotting with Ikappa Balpha - and Ikappa Bbeta -specific antibodies (upper panel).

However, in the case of NF-kappa B associated with Ikappa Balpha , it is unclear which of the NES motifs present on p65 and Ikappa Balpha plays a dominant role in the shuttling of NF-kappa B-Ikappa Balpha complexes during the preinduced state. Using p65-deficient cells, we sought to determine whether NF-kappa B-Ikappa Balpha complexes are sensitive to LMB-induced nuclear localization in the absence of the p65 subunit. As in wild-type cells, TNF-alpha still targeted the degradation of both Ikappa Balpha and Ikappa Bbeta and induced the appearance of NF-kappa B (primarily p50 and c-Rel [4]) binding activity in p65 knockout cells (Fig. 1C, lower panel, lanes 1 and 2). As in wild-type cells, LMB still inhibited the degradation of Ikappa Balpha (Fig. 1C, upper panel, lanes 3 to 5). Coupled with our earlier observation that disruption of Ikappa Balpha N-NES sequence causes nuclear accumulation of associated NF-kappa B complexes (17), our results demonstrate that Ikappa Balpha is the primary target of LMB action. These observations together demonstrate that during the preinduced state, the NF-kappa B-Ikappa Balpha complexes still shuttle between the cytoplasm and the nucleus even in the absence of the p65 NES.

Ikappa Bbeta is insensitive to LMB-induced nuclear accumulation in preinduction state. The above data suggest that NF-kappa B-Ikappa Bbeta complexes do not shuttle in an LMB-sensitive fashion, unlike those containing Ikappa Balpha . To directly determine whether the subcellular localization of preinduced Ikappa Bbeta is not affected by LMB, endogenous Ikappa Bbeta was stained with Ikappa Bbeta -specific antibodies and visualized under a fluorescent microscope. As an internal control, Ikappa Balpha subcellular localization was similarly monitored. In untreated MEFs, both Ikappa Bbeta and Ikappa Balpha were localized predominantly in the cytoplasm (Fig. 2A, upper left panels). Upon treatment of the cells with LMB, Ikappa Balpha accumulated in the nucleus, as expected (Fig. 2A, upper right panels). In contrast, the localization of Ikappa Bbeta remained cytoplasmic. To ensure that selective nuclear accumulation of Ikappa Balpha but not Ikappa Bbeta was achieved upon LMB treatment within the same cell, Cos cells were cotransfected with HA-tagged Ikappa Balpha , Ikappa Bbeta , and p50-p65 NF-kappa B subunits. Transfected cells were costained with antibodies specific to HA or Ikappa Bbeta , and localizations of Ikappa Balpha and Ikappa Bbeta proteins were determined within the same cell. Exogenous Ikappa Balpha was sensitive to LMB-induced nuclear accumulation, while Ikappa Bbeta did not migrate substantially into the nucleus (Fig. 2B, upper and middle panels). These results demonstrate that cytoplasmic localization of inactive NF-kappa B is controlled by at least two different mechanisms. When NF-kappa B is complexed with Ikappa Balpha , the mechanism of localization is determined by the kinetics of nucleocytoplasmic shuttling, with nuclear export being dominant during the preinduced state. However, cytoplasmic localization of NF-kappa B-Ikappa Bbeta is not regulated by an LMB-sensitive export mechanism.


View larger version (31K):
[in this window]
[in a new window]
 
FIG. 2.   NF-kappa B-Ikappa Bbeta complexes do not shuttle between cytoplasm and nucleus in an LMB-sensitive manner. (A) Wild-type MEFs were untreated or treated with LMB (20 ng/ml for 30 min), fixed, and stained with either Ikappa Bbeta (C-20) or Ikappa Balpha (C-21) antibodies. Cells were also costained with rhodamine-conjugated phalloidin to visualize actin for cell cytoskeleton integrity. For control, cells were also treated with LMB or TNF-alpha as above and localization of p65 (C-20) was assessed. (B) Cos-7 cells were cotransfected with HA-tagged Ikappa Balpha (1.0 µg), Ikappa Bbeta (1.0 µg), p50 (1.0 µg), and p65 (1.0 µg) constructs, untreated or treated with LMB as described for panel A, and stained with HA (red) and Ikappa Bbeta (green) antibodies. Cells were also stained with Hoechst DNA dye (blue).

NF-kappa B cannot be sequentially activated without Ikappa Balpha . It was recently shown that when the Ikappa Bbeta gene was replaced into the Ikappa Balpha locus under control of the Ikappa Balpha promoter, it could repress nuclear NF-kappa B DNA-binding activity following pulse induction with TNF-alpha (6). Thus, it was concluded that Ikappa Bbeta is functionally equivalent to Ikappa Balpha . However, we hypothesize that the export of NF-kappa B following the repression of NF-kappa B DNA-binding activity allows the system to become permissive for reactivation or postrepression activation of NF-kappa B. If NF-kappa B-Ikappa B complexes are nuclear, reactivation by a second round of stimulation would not occur, since the activation event takes place primarily in the cytoplasmic compartment. To directly test this hypothesis, we first established the condition in which postinduction repression of NF-kappa B DNA-binding activity can be reproducibly detected using both wild-type and Ikappa Balpha -deficient MEFs (Fig. 3). As expected, resynthesis of Ikappa Balpha directly correlated with the reduction of NF-kappa B DNA-binding activity in wild-type cells (Fig. 3A and B, lanes 3 to 6). Similarly, NF-kappa B DNA-binding activity decreased, in good agreement with increased Ikappa Bbeta protein levels in Ikappa Balpha -deficient cells, but this effect required longer durations due to the lack of NF-kappa B-dependent transcription of the Ikappa Bbeta gene (Fig. 3A and B, lanes 6 and 14). Once these conditions were established, MEFs were pulse stimulated with TNF-alpha and then chased with medium without TNF-alpha for 2 h before reactivation studies were performed (diagram in Fig. 4). Secondary stimulation of these cells with TNF-alpha reactivated NF-kappa B DNA-binding activity in wild-type cells (Fig. 4A, compare lanes 3 and 4). Importantly, while degradation of Ikappa Balpha was observed during the reactivation phase, Ikappa Bbeta was mostly refractory to this process (Fig. 4A and B, lower panels, lanes 4). Consistent with the above observation and also with our hypothesis, TNF-alpha could not efficiently activate NF-kappa B for the second time in the absence of Ikappa Balpha (Fig. 4B, lower panel, lanes 2 to 4). These results for the first time demonstrate that the postrepression activation of NF-kappa B requires the NF-kappa B-dependent resynthesis of Ikappa Balpha , which cannot be compensated for by other Ikappa B family members.


View larger version (43K):
[in this window]
[in a new window]
 
FIG. 3.   Kinetic analyses of postinduction repression of NF-kappa B DNA-binding activity in the presence and absence of Ikappa Balpha protein. (A) Wild-type and Ikappa Balpha -deficient MEFs were pulse treated for 10 min with TNF-alpha (10 ng/ml; lanes 2 to 6 and 8 to 14) and subsequently chased with fresh medium without TNF-alpha for the indicated amounts of time (0, 15, 30, 45, 60, 90, and 120 min). Lanes 1 and 7, untreated control samples. Total cell extracts from the samples were analyzed by Western blotting using Ikappa Balpha - and Ikappa Bbeta -specific antibodies (A) and EMSA as described above (B).


View larger version (24K):
[in this window]
[in a new window]
 
FIG. 4.   NF-kappa B cannot be sequentially activated in the absence of Ikappa Balpha . (A) Wild-type MEFs were treated with TNF-alpha (10 ng/ml for 10 min; lanes 2 to 4), then chased with fresh medium for 120 min (lanes 3 and 4), and finally restimulated with TNF-alpha as above for 10 min (lane 4). Total cell extracts were analyzed by both EMSA (upper panel) and Western blotting (lower panel). The experimental setup is diagrammed above. Numbers in parentheses signify the lanes of the sample that were treated. (B) Ikappa Balpha -deficient MEFs were treated as described above. Ikappa Balpha - and Ikappa Bbeta -specific antibodies were used in both A and B.

Postinduction export of nuclear NF-kappa B is inefficient in the absence of Ikappa Balpha . Our EMSA analyses indicate that postinduction export of inactive NF-kappa B complexes out of the nucleus requires the presence of Ikappa Balpha . To directly determine the localization of NF-kappa B-Ikappa B complexes during the postinduction phase, we examined the localization of the endogenous p65 by immunofluorescence in wild-type and Ikappa Balpha -/- MEFs. The outline of the postinduction export experiment is diagrammed in Fig. 5. Consistent with NF-kappa B-dependent synthesis of Ikappa Balpha within 30 to 60 min post-TNF-alpha stimulation (Fig. 3), nuclear p65 in the wild-type cells was efficiently exported out to the cytoplasm within 60 min of chase without TNF-alpha (Fig. 5, panels C and D). Inclusion of cycloheximide or LMB during the chase period blocked the export of p65 (Fig. 5, panels G and H), demonstrating that nuclear export of NF-kappa B during the postinduction phase indeed requires Ikappa Balpha resynthesis and an NES-dependent process. However, in the Ikappa Balpha -deficient MEFs, the majority of p65 remained in the nucleus after 60 min during the chase period (Fig. 5, panel K). Even after 3 h of chase, a large pool of p65 was nuclear (panels L and M), correlating with the resistance of NF-kappa B to reactivation by TNF-alpha (Fig. 4). Interestingly, adding LMB during the chase period caused a further increase in the amount of p65 in the nucleus (panel O). This observation suggests that an NES-dependent process was responsible for some p65 export during the prolonged chase period in Ikappa Balpha -deficient cells. These observations together demonstrate that while efficient and rapid export of NF-kappa B during postinduction phase requires the resynthesis of Ikappa Balpha , it can be exported less effectively in the absence of Ikappa Balpha , possibly via the recently identified NES on the p65 subunit.


View larger version (20K):
[in this window]
[in a new window]
 
FIG. 5.   Postinduction export of NF-kappa B is sensitive to LMB and inefficient in the absence of Ikappa Balpha . Wild-type and Ikappa Balpha -deficient MEFs were treated with TNF-alpha (10 ng/ml for 10 min; panels B to H and J to O) and chased with fresh medium for the indicated amounts of time (60, 120, or 180 min) in the presence or absence of cycloheximide (CX; 10 µg/ml) or LMB (20 ng/ml). The experimental setup is diagrammed above. The treated cells were then fixed and the endogenous p65 was stained with p65 (C-20)-specific antibody.

Ikappa Bbeta can enter the nucleus but is not efficiently exported during postinduction phase. The observations thus far suggest that NF-kappa B associated with Ikappa Balpha is exported efficiently but NF-kappa B associated with Ikappa Bbeta is not during the postinduction phase. Direct examination of subcellular localization of Ikappa Bbeta during postinduction phase by both immunofluorescence and biochemical subfractionation analyses confirmed that indeed newly synthesized Ikappa Bbeta can enter the nucleus (Fig. 6A, vector only, panel 3, and 6B, compare Ikappa Bbeta , lane 7). Interestingly, the signal detected by C20 anti-Ikappa Bbeta antibody in immunofluorescence showed a similar extent of degradation as with Ikappa Balpha after 30 min of TNF-alpha stimulation (Fig. 6A, compare panels 2), but Western blot analyses consistently showed incomplete Ikappa Bbeta degradation compared to Ikappa Balpha within the same time frame (Fig. 6B, Ikappa Bbeta and Ikappa Balpha , lanes 2). The significance of this observation is discussed below (see Discussion). Importantly, while the presence of nuclear Ikappa Bbeta correlated well with the repression of NF-kappa B DNA-binding activity in Ikappa Balpha -deficient cells, Ikappa Bbeta was not exported out of the nucleus even up to 3 h during the chase period. LMB showed very little effect during the chase period (Fig. 6A, panel 4), suggesting that subcellular localization of Ikappa Bbeta is not affected by an NES-dependent export process. The lack of nuclear export of Ikappa Bbeta was not due to some defect of the Ikappa Balpha -deficient cell system used because when Ikappa Balpha tagged with the HA epitope (HA-Ikappa Balpha ) was stably expressed, HA-Ikappa Balpha was efficiently exported during the postinduction phase in an LMB-sensitive fashion in a manner identical to endogenous Ikappa Balpha in wild-type cells (Fig. 6A, HA-Ikappa Balpha , panels 3 and 4). These results demonstrate that while newly synthesized Ikappa Bbeta can enter the nucleus, it fails to export efficiently out of the nucleus during the postinduction phase.


View larger version (48K):
[in this window]
[in a new window]
 
FIG. 6.   N-terminal region containing the N-NES of Ikappa Balpha is sufficient to mediate the postinduction export function. (A) Ikappa Balpha -deficient MEFs were stably transfected with either vector (vector only), HA-tagged Ikappa Balpha (HA-Ikappa Balpha ), Ikappa Balpha beta beta chimera (Ikappa Balpha beta beta ), or N-terminal NES mutant Ikappa Balpha beta beta chimera contructs (Ikappa Balpha beta beta N-NESmut). Pools of stable transfectants were isolated, and subcellular localization of Ikappa Bs was visualized using antibodies against Ikappa Bbeta (C-20, vector only), Ikappa Balpha (C-21, HA-Ikappa Balpha ), N-terminal 56 amino acids of Ikappa Balpha (5432, Ikappa Balpha beta beta , and Ikappa B alpha beta beta N-NESmut). The cells were also treated with TNF-alpha for 60 min (panels 2 to 4), chased with fresh medium for 180 min (panels 3), or in the presence of LMB (panels 4). (B) Stably transfected MEFs as above were either untreated (lanes 1 and 5), pulsed with TNF-alpha for 30 min (lanes 2 and 6), chased with fresh growth medium for 120 min (lanes 3 and 7), and rechallenged with TNF-alpha for another 30 min (lanes 4 and 8). Samples from each pool of cells were fractionated as described in Materials and Methods and analyzed by Western blotting using antibodies against Ikappa Bbeta (C-20), Ikappa Balpha (C-21), and amino-terminal Ikappa Balpha (5432) for the detection of the chimera protein. Samples from vector only, HA-Ikappa Balpha , Ikappa Balpha beta beta , or Ikappa Balpha beta beta N-NESmut are shown as panels with arrows indicating Ikappa Bbeta , HA-Ikappa Balpha , Ikappa Balpha beta beta or Ikappa Balpha beta beta N-NESmut, respectively.

Ikappa Balpha N-NES is sufficient to mediate postinduction export function. There are a total of three independent NES motifs reported on Ikappa Balpha -NF-kappa B complexes, the N- and C- terminal NES motifs on Ikappa Balpha and a p65 NES (2, 16, 17, 23, 40, 43). There is a controversy as to which of these putative NES sequences provide(s) the dominant nuclear export function for the complexes during the postinduction phase. To conclusively determine whether N-NES is sufficient to dominantly export the NF-kappa B-Ikappa B complexes in the absence of C-NES, we asked whether Ikappa Balpha N-terminal to the first ankyrin repeat could support dominant nuclear export function in the context of Ikappa Bbeta protein. We therefore generated an Ikappa Bbeta chimera expression construct in which the Ikappa Bbeta N-terminal region upstream of the first ankyrin repeat was swapped with the N-terminal aa 1 to 66 of Ikappa Balpha (Ikappa Balpha beta beta ) and stably expressed it in Ikappa Balpha -deficient MEFs. Similar to HA-Ikappa Balpha , the chimeric protein was largely expressed in the cytoplasm (Fig. 6A, panel 1) and associated with NF-kappa B as demonstrated by a coimmunoprecipitation assay (not shown). Degradation of Ikappa Balpha beta beta after pulse stimulation with TNF-alpha was complete like Ikappa Balpha but unlike Ikappa Bbeta (Fig. 6A, Ikappa Balpha beta beta , panel 2; Fig. 6B, Ikappa Balpha beta beta , lane 2). Importantly, resynthesized Ikappa Balpha beta beta was predominantly cytoplasmic, but LMB during the chase period trapped it in the nucleus (Fig. 6A, Ikappa Balpha beta beta , panels 3 and 4). These results suggest that the N-terminal sequence of Ikappa Balpha was able to dominantly export the chimeric complexes out of the nucleus.

To formally demonstrate that the export function of Ikappa Balpha beta beta is mediated by the N-NES of Ikappa Balpha , we mutated the NES sequence in the context of Ikappa Balpha beta beta (Ikappa Balpha beta beta N-NESmut), as described previously (17). Ikappa Balpha beta beta N-NESmut was also stably introduced in the Ikappa Balpha knockout MEFs. If N-NES is dominant for the localization of NF-kappa B-Ikappa Balpha beta beta complexes, then we expected that the steady-state localization of the complexes would be nuclear in unstimulated cells. However, if N-NES had a minor effect, the complexes would be expected to be predominantly cytoplasmic. Our immunolocalization and biochemical fractionation analyses demonstrated that Ikappa Balpha beta beta N-NESmut was predominantly nuclear in unstimulated cells (Fig. 6A, Ikappa Balpha beta beta N-NESmut, panel 1; Fig. 6B, Ikappa Balpha beta beta N-NESmut, lane 5). The mutant protein was still able to associate with NF-kappa B in a co-immunoprecipitation assay (not shown). The nuclear Ikappa Balpha beta beta N-NESmut was refractory to TNFalpha -induced degradation (Fig. 6A, panel 2; Fig. 6B, lane 6), consistent with the hypothesis that NF-kappa B activation requires its cytoplasmic localization. These findings demonstrate that N-NES of Ikappa Balpha is sufficient to confer export function that is dominant over any known NES sequences present on inactive NF-kappa B-Ikappa B complexes.

Postrepression activation of NF-kappa B also requires the Ikappa Balpha N-NES. Using a biochemical subfractionation assay, we also tested whether the postinduction-resynthesized Ikappa Bbeta , HA-Ikappa Balpha , and Ikappa Balpha beta beta proteins in the context of Ikappa Balpha knockout cells were capable of being degraded following a second stimulation with TNF-alpha (Fig. 6B). Although resynthesized nuclear Ikappa Bbeta protein was refractory to restimulation with TNF-alpha , reconstituted HA-Ikappa Balpha was capable of being degraded in response to a second TNF-alpha challenge (Fig. 6B, Ikappa Bbeta , lanes 7 and 8; HA-Ikappa Balpha , lanes 3 and 4). Moreover, resynthesized Ikappa Balpha beta beta was also subjected to degradation following restimulation with TNF-alpha , demonstrating that the Ikappa Balpha N-NES is sufficient to confer export function on the Ikappa Bbeta protein to mediate postrepression activation of NF-kappa B (Fig. 6B, Ikappa Balpha beta beta , lanes 3 and 4).


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Recently, several groups, including ours, discovered that NF-kappa B-Ikappa Balpha inactive complexes shuttle continuously between the nuclear and cytoplasmic compartments to achieve a predominant cytoplasmic localization during the absence of NF-kappa B-activating signals (17, 23, 38, 43). Maintaining the cytoplasmic localization of the inactive complexes is essential for NF-kappa B function, since signals derived from either the plasma membrane or the nucleus to target the degradation of Ikappa Balpha are blocked if the inactive complexes are sequestered in the nuclear compartment (17, 18, 38). We therefore asked whether regulation of NF-kappa B by nucleocytoplasmic shuttling was a conserved mechanism of all Ikappa B family members that negatively influence the important NF-kappa B family of transcriptional regulators.

By scanning the primary amino acid sequences, we failed to identify a similar N-NES motif present in Ikappa Balpha in the N-terminal regions of mammalian Ikappa Bbeta , p105/Ikappa Bgamma , p100, Ikappa Bvarepsilon , Bcl-3, and the Drosophila Ikappa B homolog cactus (Fig. 1A). A classical NES sequence was also undetected in other regions of the Ikappa B family members. These observations suggested that Ikappa Balpha might be the only Ikappa B family member that contained a novel nuclear export capacity to mediate rapid export of nuclear NF-kappa B. These sequence analyses further implied that Ikappa Balpha might be a more recently evolved family member. Coincidentally, Ikappa Balpha is one of the major NF-kappa B target genes in mammalian cells, which forms the autoinhibitory feedback loop to perform the postinduction repression of NF-kappa B function. Even without the presence of a conserved N-terminal NES on Ikappa Bbeta , we could not rule out the possibility that the NF-kappa B-Ikappa Bbeta complexes still shuttle in an LMB-sensitive manner, since a recent report has shown that the p65 subunit of NF-kappa B possesses a bona fide NES motif (16).

In the present study, we found that LMB selectively blocked the signal-induced degradation of Ikappa Balpha but not Ikappa Bbeta . Ikappa Balpha knockout cells confirmed that TNFalpha -induced NF-kappa B activation cannot be inhibited by LMB in the absence of Ikappa Balpha , since NF-kappa B-Ikappa Bbeta , and possibly other NF-kappa B-Ikappa B complexes, is insensitive to the LMB effect in these cells. Moreover, unlike Ikappa Balpha -containing NF-kappa B complexes, NF-kappa B-Ikappa Bbeta complexes that contained the p65 subunit were still largely refractory to LMB-induced nuclear accumulation. These surprising results enabled us to modify the NF-kappa B cytoplasmic sequestration model (3, 12), in which Ikappa B proteins, excluding Ikappa Balpha , are likely proficient in masking the dual NF-kappa B NLS motifs. Studies with Ikappa Balpha beta beta suggest that the N-terminal sequence of Ikappa Bbeta is required for efficient masking of NF-kappa B NLS sequences, since swapping of this region with that of Ikappa Balpha permitted NF-kappa B associated with the chimera protein to shuttle between the cytoplasm and nucleus (Fig. 6 and unpublished observation).

The NF-kappa B-Ikappa Balpha complexes, on the other hand, behave differently from other Ikappa B proteins in that cytoplasmic localization of the complexes is a result of a dynamic balance between nuclear import and active nuclear export forces. This notion is further supported by the observation of incomplete p50 NLS masking by Ikappa Balpha ankyrin repeats in NF-kappa B-Ikappa Balpha cocrystals (19, 22) and the finding that the p65 NLS but not the p50 NLS motif is involved in direct association with Ikappa Balpha (36). Even though at least three NES motifs have been identified in the NF-kappa B-Ikappa Balpha trimeric complex (2, 16, 17, 23, 40, 43), our data demonstrate that their nucleocytoplasmic shuttling is dominantly controlled by the Ikappa Balpha N-NES motif, since (i) these complexes do not efficiently shuttle when the Ikappa Balpha N-NES is mutated or deleted (17), (ii) an Ikappa Balpha C-NES mutation has little effect on shuttling of the complexes (17, 23, 43), (iii) they also efficiently shuttle without p65 protein or when p65-NES is deleted (unpublished observation), and (iv) the Ikappa Balpha N-NES is sufficient to confer dominant shuttling function when grafted onto the Ikappa Bbeta protein.

What is unclear is whether there are any physiological advantages to maintaining an energy-consuming and apparently futile shuttling process in order to preserve the asymmetric distribution of NF-kappa B-Ikappa Balpha complexes in the preinduced state. Perhaps it is more efficient to regulate the localization of shuttling proteins by simply adjusting the rate of nuclear entry versus export in order to drastically alter the steady-state subcellular distribution of the complexes. It is conceivable that as yet undiscovered physiological control of NF-kappa B activity may exist which involves the altered regulation of nucleocytoplasmic shuttling of the inactive complexes. Adjusting the kinetics of shuttling by having the rate of import exceed the rate of export may be a novel mechanism to attenuate NF-kappa B function. However, our findings suggest that, depending on the ratio of NF-kappa B associated with Ikappa Balpha or Ikappa Bbeta or other Ikappa B family members, only a subset of inactive NF-kappa B pools may be subjected to this type of regulation. This may explain why certain investigators fail to observe large effects of LMB on NF-kappa B activation in different experimental settings (23).

In contrast, what is clear from our present study is that the nuclear export function of Ikappa Balpha N-NES is essential for rapid and efficient export of inactive NF-kappa B complexes out of the nucleus during the postinduction phase. Our findings from Ikappa Balpha knockout cells demonstrate that other Ikappa B family members could not efficiently perform this function. We found, in accordance with studies using cells isolated from Ikappa Bbeta knockin mice (6), newly synthesized Ikappa Bbeta protein was able to enter the nucleus and repress NF-kappa B DNA-binding activity. However, Ikappa Bbeta , which does not possess a functional NES, could not efficiently carry NF-kappa B out of the nucleus. Thus, only Ikappa Balpha protein was able to prime the NF-kappa B system for a subsequent reactivation event or provide a permissive condition for postrepression activation to take place.

Wild-type cells, which can properly export postinduced nuclear NF-kappa B out to the cytoplasm, could efficiently respond to secondary NF-kappa B stimuli. Ikappa Balpha -deficient cells, however, were refractory to this NF-kappa B reactivation process. Thus, it is logical to consider that the initial postinduction repression of NF-kappa B DNA-binding activity is an important mechanism to rapidly shut off NF-kappa B-dependent gene transcription following a short exposure to cytokine stimulation in a biological setting. This Ikappa B-mediated repression and removal of NF-kappa B from its DNA-binding sites may be necessary, since NF-kappa B has been shown to bind its cognate sites with very slow off rates in vitro (36). In addition, efficient removal of NF-kappa B from cognate DNA-binding sites may also be critical for allowing the NF-kappa B-Ikappa Balpha complexes to interact with the soluble transport machinery, Crm1 and RanGTP (25, 28). Subsequently, the nuclear export of inactive NF-kappa B-Ikappa Balpha complexes provides another important function to allow cells to become quickly permissive for a second challenge with either cytokine, bacterial, or viral insults. Without efficient export of nuclear NF-kappa B, the secondary activation process is defective. Thus, the nuclear export function of Ikappa Balpha may contribute to the ability of an organism to respond rapidly to multiple cellular infections.

It is interesting to consider whether the N-NES of Ikappa Balpha may have evolved to permit sequential NF-kappa B activation. Because the N-NES of Ikappa Balpha needs to interact with Crm1 for export function, i.e., exposed on the surface of NF-kappa B-Ikappa Balpha complexes, this domain may have lost the capacity to efficiently mask the p50 NLS. These events may have caused the NF-kappa B-Ikappa Balpha complexes to nucleocytoplasmically shuttle in the preinduced conditions by default. Important goals of future investigation include determining how nucleocytoplasmic shuttling of NF-kappa B-Ikappa Balpha complexes is regulated and whether disruption of these regulatory mechanisms has drastic biological and/or pathological consequences.

It is well known that Ikappa Bbeta is less responsive to stimulus-induced degradation than Ikappa Balpha , as determined by Western blot analyses. However, the mechanism for this resistance is unclear. Unexpectedly, we found that when Ikappa Bbeta degradation was assessed by immunostaining using C20 Ikappa Bbeta antibody, TNF-alpha stimulation caused almost complete loss of immunoreactivity, similar to that found with Ikappa Balpha antibodies (Fig. 6). However, the same Ikappa Bbeta antibody still showed only partial degradation on Western blot analyses, consistent with the weaker responsiveness of Ikappa Bbeta to TNF-alpha -induced degradation. The pool of Ikappa Bbeta that was resistant to initial TNF-alpha stimulation remained refractory to secondary stimulation even though it remained cytoplasmic, indicating that this pool of Ikappa Bbeta is not accessible to the stimulus-induced degradation pathway. A recent study by Ghosh and colleagues found that kappa B-Ras might be critical for retarding Ikappa Bbeta degradation during the NF-kappa B activation process (9). Interestingly, the interaction between kappa B-Ras and Ikappa Bbeta is mediated by the C-terminal region of Ikappa Bbeta , which contains the epitope recognized by C20 antibody. It is possible that when kappa B-Ras is bound to Ikappa Bbeta , C20 may not recognize Ikappa Bbeta due to epitope masking. Thus, it is tempting to speculate that there are at least two pools of Ikappa Bbeta , one free of kappa B-Ras and the other associated with it. The Ikappa Bbeta pool that is free of kappa B-Ras may be accessible for immunostaining with C20 and efficiently degraded by TNF-alpha stimulation. In contrast, Ikappa Bbeta bound to kappa B-Ras might be inaccessible for immunostaining using C20 antibody and resistant to degradation. Thus, our study suggests that the C20 antibody may provide a useful tool to help elucidate the mechanism of partial degradation of Ikappa Bbeta during NF-kappa B activation processes.


    ACKNOWLEDGMENTS

We thank D. Baltimore for Ikappa Balpha knockout MEFs and p65 knockout 3T3 cells, D. Ballard for human p65 cDNA, S. Shumway for critical reading of the manuscript, and M. Yoshida for continued support and the generous gift of LMB.

This work was supported by an NIH predoctoral training grant award through the Molecular and Cellular Pharmacology graduate program to T.T.H. and NIH RO1 CA77474, a Howard Hughes Medical Institute fund through the University of Wisconsin Medical School, and the Shaw Scientist Award from the Milwaukee Foundation to S.M.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Pharmacology, University of Wisconsin---Madison, 3795 Medical Sciences Center, 1300 University Avenue, Madison, WI 53706-1532. Phone: (608) 262-9281. Fax: (608) 262-1257. E-mail: smiyamot{at}facstaff.wisc.edu.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Arenzana-Seisdedos, F., J. Thompson, M. S. Rodriguez, F. Bachelerie, D. Thomas, and R. T. Hay. 1995. Inducible nuclear expression of newly synthesized Ikappa Balpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol. Cell. Biol. 15:2689-2696[Abstract].
2. Arenzana-Seisdedos, F., T. Turpin, M. Rodriguez, D. Thomas, R. T. Hay, J.-L. Virelizier, and C. Dargemont. 1997. Nuclear localization of Ikappa Balpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J. Cell Sci. 110:369-378[Abstract].
3. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. J. Baldwin. 1992. Ikappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913[Abstract/Free Full Text].
4. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167-70[CrossRef][Medline].
5. Cao, Z. D., J. Xiong, M. Takeuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443-446[CrossRef][Medline].
6. Cheng, J. D., R. P. Ryseck, R. M. Attar, D. Dambach, and R. Bravo. 1998. Functional redundancy of the nuclear factor kappa B inhibitors Ikappa Balpha and Ikappa Bbeta . J. Exp. Med. 188:1055-1062[Abstract/Free Full Text].
7. Cheng, Q., C. A. Cant, T. Moll, R. Hofer-Warbinek, E. Wagner, M. L. Birnstiel, F. H. Bach, and R. de Martin. 1994. NF-kappa B subunit-specific regulation of the Ikappa Balpha promoter. J. Biol. Chem. 269:13551-13557[Abstract/Free Full Text].
8. Chiao, P. J., S. Miyamoto, and I. M. Verma. 1994. Autoregulation of Ikappa Balpha activity. Proc. Natl. Acad. Sci. USA 91:28-32[Abstract/Free Full Text].
9. Fenwick, C., S.-Y. Na, R. E. Voll, H. Zhong, S.-Y. Im, J. W. Lee, and S. Ghosh. 2000. A subclass of ras proteins that regulate the degradation of Ikappa B. Science 287:869-873[Abstract/Free Full Text].
10. Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060[CrossRef][Medline].
11. Fukuda, M., S. Asano, T. Nakamura, M. Adachi, M. Yoshida, M. Yanagida, and N. E.. 1997. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390:308-311[CrossRef][Medline].
12. Ganchi, P. A., S. C. Sun, W. C. Greene, and D. W. Ballard. 1992. Ikappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Mol. Biol. Cell 3:1339-1352[Abstract].
13. Geisler, R., A. Bergmann, Y. Hiromi, and C. Nusslein-Volhard. 1992. cactus, a gene involved in dorsoventral pattern formation of Drosophila, is related to the Ikappa B gene family of vertebrates. Cell 71:613-621[CrossRef][Medline].
14. Ghosh, S., A. M. Gifford, L. R. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell 62:1019-1029[CrossRef][Medline].
15. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kappa B and rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260[CrossRef][Medline].
16. Harhaj, E. W., and S. C. Sun. 1999. Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol. Cell. Biol. 19:7088-7095[Abstract/Free Full Text].
17. Huang, T. T., N. Kudo, M. Yoshida, and S. Miyamoto. 2000. A nuclear export signal in the N-terminal regulatory domain of Ikappa Balpha controls cytoplasmic localization of inactive NF-kappa B/Ikappa Balpha complexes. Proc. Natl. Acad. Sci. USA 97:1014-1019[Abstract/Free Full Text].
18. Huang, T. T., S. M. Wuerzberger-Davis, B. J. Seufzer, S. D. Shumway, T. Kurama, D. A. Boothman, and S. Miyamoto. 2000. NF-kappa B activation by camptothecin: a linkage between nuclear DNA damage and cytoplasmic signaling events. J. Biol. Chem. 275:9501-9509[Abstract/Free Full Text].
19. Huxford, T., D.-B. Huang, S. Malek, and G. Ghosh. 1998. The crystal structure of the Ikappa Ba/NF-kappa B complex reveals mechanisms of NF-kappa B inactivation. Cell 95:759-770[CrossRef][Medline].
20. Inoue, J., L. D. Kerr, A. Kakizuka, and I. M. Verma. 1992. Ikappa Bgamma , a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the Ikappa B family. Cell 68:1109-1120[CrossRef][Medline].
21. Ito, C. Y., A. G. Kazantsev, and A. S. J. Baldwin. 1994. Three NF-kappa B sites in the Ikappa Balpha promoter are required for induction of gene expression by TNFalpha . Nucleic Acids Res. 22:3787-3792[Abstract/Free Full Text].
22. Jacobs, M. D., and S. C. Harrison. 1998. Structure of an Ikappa Balpha /NF-kappa B complex. Cell 95:749-758[CrossRef][Medline].
23. Johnson, C., D. V. Antwerp, and T. J. Hope. 1999. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of Ikappa Balpha . EMBO J. 18:6682-6693[CrossRef][Medline].
24. Kaffman, A., and E. K. O'Shea. 1999. Regulation of nuclear localization: a key to a door. Annu. Rev. Cell Dev. Biol. 15:291-339[CrossRef][Medline].
25. Kudo, N., N. Matsumori, H. Taoka, D. Fujiwara, E. P. Schreiner, B. Wolff, M. Yoshida, and S. Horinouchi. 1999. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. USA 96:9112-9117[Abstract/Free Full Text].
26. Kudo, N., B. Wolff, T. Sekimoto, E. P. Schreiner, Y. Yoneda, M. Yanagida, S. Horinouchi, and M. Yoshida. 1998. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:540-547[CrossRef][Medline].
27. Le Bail, O., R. Schmidt-Ullrich, and A. Israel. 1993. Promoter analysis of the gene encoding the Ikappa Balpha /MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J. 12:5043-5049[Medline].
28. Mattaj, I. W., and L. Englmeier. 1998. Nucleocytoplasmic transport: the soluble phase. Annu. Rev. Biochem. 67:265-306[CrossRef][Medline].
29. Mercurio, F., J. A. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. Genes Dev. 7:705-718[Abstract/Free Full Text].
30. Miyamoto, S., P. J. Chiao, and I. M. Verma. 1994. Enhanced Ikappa Balpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines. Mol. Cell. Biol. 14:3276-3282[Abstract/Free Full Text].
31. Miyamoto, S., B. Seufzer, and S. Shumway. 1998. Novel Ikappa Balpha degradation process in WEHI231 murine immature B cells. Mol. Cell. Biol. 18:19-29[Abstract/Free Full Text].
32. Naviaux, R. K., E. Costanzi, M. Hass, and I. M. Verma. 1996. The pCL vector system---rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701-5705[Abstract/Free Full Text].
33. Neri, A., C. C. Chang, L. Lombardi, M. Salina, P. Corradini, A. T. Maiolo, R. S. Chaganti, and R. Dalla-Favera. 1991. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell 67:1075-1087[CrossRef][Medline].
34. Ohno, H., G. Takimoto, and T. W. McKeithan. 1990. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991-997[CrossRef][Medline].
35. Ossareh-Nazari, B., F. Bachelerie, and C. Dargemont. 1997. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278:141-144[Abstract/Free Full Text].
36. Phelps, C. B., L. L. Sengchanthalangsy, T. Huxford, and G. Ghosh. 2000. Mechanisms of Ikappa Balpha binding to NF-kappa B dimers. J. Biol. Chem. 275:29840-29846[Abstract/Free Full Text].
37. Rice, N. R., M. L. MacKichan, and A. Israel. 1992. The precursor of NF-kappa B p50 has Ikappa B-like functions. Cell 71:243-253[CrossRef][Medline].
38. Rodriguez, M. S., J. Thompson, R. T. Hay, and C. Dargemont. 1999. Nuclear retention of Ikappa Balpha protects it from signal-induced degradation and inhibits nuclear factor kappa B transcriptional activation. J. Biol. Chem. 274:9108-9115[Abstract/Free Full Text].
39. Sachdev, S., S. Bagchi, D. D. Zhang, A. C. Mings, and M. Hannink. 2000. Nuclear import of Ikappa Balpha is accomplished by a ran-independent transport pathway. Mol. Cell. Biol. 20:1571-1582[Abstract/Free Full Text].
40. Sachdev, S., and M. Hannink. 1998. Loss of Ikappa Balpha -mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel. Mol. Cell. Biol. 18:5445-5456[Abstract/Free Full Text].
41. Stade, K., C. S. Ford, C. Guthrie, and K. Weis. 1997. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 90:1041-1050[CrossRef][Medline].
42. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-kappa B controls expression of inhibitor Ikappa Balpha : evidence for an inducible autoregulatory pathway. Science 259:1912-1915[Abstract/Free Full Text].
43. Tam, W. F., L. H. Lee, L. Davis, and R. Sen. 2000. Cytoplasmic sequestration of rel proteins by Ikappa Balpha requires Crm1-dependent nuclear export. Mol. Cell. Biol. 20:2269-2284[Abstract/Free Full Text].
44. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. Ikappa Bbeta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80:573-582[CrossRef][Medline].
45. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/Ikappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735[Free Full Text].
46. Whiteside, S. T., J.-C. Epinat, N. R. Rice, and A. Israel. 1997. Ikappa Bvarepsilon , a novel member of the Ikappa B family, controls RelA and cRel NF-kappa B activity. EMBO J. 16:1413-1426[CrossRef][Medline].
47. Zabel, U., and P. A. Baeuerle. 1990. Purified human Ikappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell 61:255-265[CrossRef][Medline].


Molecular and Cellular Biology, July 2001, p. 4737-4747, Vol. 21, No. 14
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.14.4737-4747.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Liberatore, R. A., Goff, S. P., Nunes, I. (2009). NF-{kappa}B activity is constitutively elevated in c-Abl null fibroblasts. Proc. Natl. Acad. Sci. USA 106: 17823-17828 [Abstract] [Full Text]  
  • Ghafoori, P., Yoshimura, T., Turpie, B., Masli, S. (2009). Increased I{kappa}B{alpha} expression is essential for the tolerogenic property of TGF-{beta}-exposed APCs. FASEB J. 23: 2226-2234 [Abstract] [Full Text]  
  • Lindstrom, T. M., Mohan, A. R., Johnson, M. R., Bennett, P. R. (2008). Histone Deacetylase Inhibitors Exert Time-Dependent Effects on Nuclear Factor-{kappa}B but Consistently Suppress the Expression of Proinflammatory Genes in Human Myometrial Cells. Mol. Pharmacol. 74: 109-121 [Abstract] [Full Text]  
  • Williams, J. L., Ji, P., Ouyang, N., Liu, X., Rigas, B. (2008). NO-donating aspirin inhibits the activation of NF-{kappa}B in human cancer cell lines and Min mice. Carcinogenesis 29: 390-397 [Abstract] [Full Text]  
  • Qu, J., Liu, G.-H., Huang, B., Chen, C. (2007). Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of Cysteines 93 and 310. Nucleic Acids Res 35: 2522-2532 [Abstract] [Full Text]  
  • Silk, R. N., Bowick, G. C., Abrams, C. C., Dixon, L. K. (2007). African swine fever virus A238L inhibitor of NF-{kappa}B and of calcineurin phosphatase is imported actively into the nucleus and exported by a CRM1-mediated pathway. J. Gen. Virol. 88: 411-419 [Abstract] [Full Text]  
  • Berchtold, C. M., Wu, Z.-H., Huang, T. T., Miyamoto, S. (2007). Calcium-Dependent Regulation of NEMO Nuclear Export in Response to Genotoxic Stimuli. Mol. Cell. Biol. 27: 497-509 [Abstract] [Full Text]  
  • Aguilera, C., Fernandez-Majada, V., Ingles-Esteve, J., Rodilla, V., Bigas, A., Espinosa, L. (2006). Efficient nuclear export of p65-I{kappa}B{alpha} complexes requires 14-3-3 proteins.. J. Cell Sci. 119: 3695-3704 [Abstract] [Full Text]  
  • Ganesh, L., Yoshimoto, T., Moorthy, N. C., Akahata, W., Boehm, M., Nabel, E. G., Nabel, G. J. (2006). Protein Methyltransferase 2 Inhibits NF-{kappa}B Function and Promotes Apoptosis. Mol. Cell. Biol. 26: 3864-3874 [Abstract] [Full Text]  
  • Kang, B.-N., Tirumurugaan, K. G., Deshpande, D. A., Amrani, Y., Panettieri, R. A., Walseth, T. F., Kannan, M. S. (2006). Transcriptional regulation of CD38 expression by tumor necrosis factor-{alpha} in human airway smooth muscle cells: role of NF-{kappa}B and sensitivity to glucocorticoids. FASEB J. 20: 1000-1002 [Abstract] [Full Text]  
  • Xiong, Y., Kotake, Y. (2006). No exit strategy? No problem: APC inhibits beta-catenin inside the nucleus.. Genes Dev. 20: 637-642 [Full Text]  
  • Mittal, A., Papa, S., Franzoso, G., Sen, R. (2006). NF-{kappa}B-Dependent Regulation of the Timing of Activation-Induced Cell Death of T Lymphocytes. J. Immunol. 176: 2183-2189 [Abstract] [Full Text]  
  • Lindstrom, T. M, Bennett, P. R (2005). The role of nuclear factor kappa B in human labour. Reproduction 130: 569-581 [Abstract] [Full Text]  
  • Wuerzberger-Davis, S. M., Chang, P.-Y., Berchtold, C., Miyamoto, S. (2005). Enhanced G2-M Arrest by Nuclear Factor-{kappa}B-Dependent p21waf1/cip1 Induction. Mol Cancer Res 3: 345-353 [Abstract] [Full Text]  
  • O'Connor, S., Shumway, S., Miyamoto, S. (2005). Inhibition of I{kappa}B{alpha} Nuclear Export as an Approach to Abrogate Nuclear Factor-{kappa}B-Dependent Cancer Cell Survival. Mol Cancer Res 3: 42-49 [Abstract] [Full Text]  
  • Lahav, G. (2004). The Strength of Indecisiveness: Oscillatory Behavior for Better Cell Fate Determination. Sci Signal 2004: pe55-pe55 [Abstract] [Full Text]  
  • Aguilera, C., Hoya-Arias, R., Haegeman, G., Espinosa, L., Bigas, A. (2004). Recruitment of I{kappa}B{alpha} to the hes1 promoter is associated with transcriptional repression. Proc. Natl. Acad. Sci. USA 101: 16537-16542 [Abstract] [Full Text]  
  • Verma, I M (2004). Nuclear factor (NF)-{kappa}B proteins: therapeutic targets. Ann Rheum Dis 63: ii57-ii61 [Full Text]  
  • Ajenjo, N., Canon, E., Sanchez-Perez, I., Matallanas, D., Leon, J., Perona, R., Crespo, P. (2004). Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells. J. Biol. Chem. 279: 32813-32823 [Abstract] [Full Text]  
  • Takahashi, S., McConnell, M. J., Harigae, H., Kaku, M., Sasaki, T., Melnick, A. M., Licht, J. D. (2004). The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT. Blood 103: 4650-4658 [Abstract] [Full Text]  
  • Viatour, P., Legrand-Poels, S., van Lint, C., Warnier, M., Merville, M.-P., Gielen, J., Piette, J., Bours, V., Chariot, A. (2003). Cytoplasmic I{kappa}B{alpha} Increases NF-{kappa}B-independent Transcription through Binding to Histone Deacetylase (HDAC) 1 and HDAC3. J. Biol. Chem. 278: 46541-46548 [Abstract] [Full Text]  
  • Xia, J., Lee, D. H., Taylor, J., Vandelft, M., Truant, R. (2003). Huntingtin contains a highly conserved nuclear export signal. Hum Mol Genet 12: 1393-1403 [Abstract] [Full Text]  
  • Malek, S., Huang, D.-B., Huxford, T., Ghosh, S., Ghosh, G. (2003). X-ray Crystal Structure of an I{kappa}B{beta}{middle dot}NF-{kappa}B p65 Homodimer Complex. J. Biol. Chem. 278: 23094-23100 [Abstract] [Full Text]  
  • Chen, Y., Wu, J., Ghosh, G. (2003). {kappa}B-Ras Binds to the Unique Insert within the Ankyrin Repeat Domain of I{kappa}B{beta} and Regulates Cytoplasmic Retention of I{kappa}B{beta}{middle dot}NF-{kappa}B Complexes. J. Biol. Chem. 278: 23101-23106 [Abstract] [Full Text]  
  • Espinosa, L., Ingles-Esteve, J., Robert-Moreno, A., Bigas, A. (2003). Ikappa Balpha and p65 Regulate the Cytoplasmic Shuttling of Nuclear Corepressors: Cross-talk between Notch and NFkappa B Pathways. Mol. Biol. Cell 14: 491-502 [Abstract] [Full Text]  
  • Mizgerd, J. P., Scott, M. L., Spieker, M. R., Doerschuk, C. M. (2002). Functions of I{kappa}B Proteins in Inflammatory Responses to Escherichia coli LPS in Mouse Lungs. Am. J. Respir. Cell Mol. Bio. 27: 575-582 [Abstract] [Full Text]  
  • Kawai, H., Nie, L., Yuan, Z.-M. (2002). Inactivation of NF-{kappa}B-Dependent Cell Survival, a Novel Mechanism for the Proapoptotic Function of c-Abl. Mol. Cell. Biol. 22: 6079-6088 [Abstract] [Full Text]  
  • Huang, T. T., Feinberg, S. L., Suryanarayanan, S., Miyamoto, S. (2002). The Zinc Finger Domain of NEMO Is Selectively Required for NF-{kappa}B Activation by UV Radiation and Topoisomerase Inhibitors. Mol. Cell. Biol. 22: 5813-5825 [Abstract] [Full Text]  
  • Lee, S.-H., Hannink, M. (2002). Characterization of the Nuclear Import and Export Functions of Ikappa Bepsilon. J. Biol. Chem. 277: 23358-23366 [Abstract] [Full Text]  
  • Brivanlou, A. H., Darnell, J. E. Jr. (2002). Signal Transduction and the Control of Gene Expression. Science 295: 813-818 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, T. T.
Right arrow Articles by Miyamoto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, T. T.
Right arrow Articles by Miyamoto, S.